The last 50 years has produced a proliferation of innovations in healthcare aimed at enhancing quality of life, diagnostic and treatment options, as well as improving efficiency and cost effectiveness of the healthcare system. The rapid emergence of advanced skin care technologies has propelled dermatology and wound management into the high-tech end of the medical technology market which is not always supported by a robust evidence base. This module provides an overview of the adoption of innovative drugs, devices, diagnostics and services for patients with compromised skin integrity and is intended for those who would benefit from a better understanding of the process of healthcare innovation from a clinical perspective.

Who Should Attend?

This module is compulsory for the MSc Skin Integrity and Wound Management but is an optional mdoule for students on the MSc Skin Lesion Management. It will be of interest to GPs, FY1-2/ GP ST 1- 3’s, Specialist Nurses, Podiatrists, Pharmacists, and Clinical Advisors in Industry with an interest in wound care and skin conditions.

Content

Students will study a selection of topics such as:

• Global skin care trends in the 'medical marketplace'

• Commercial development/design of new medical technology products and services

• Adoption of innovative drugs, devices and diagnostics

• Cost effectiveness, affordability and value for money

• Strategies to support healthcare innovation: business plan writing, consultancy and enterprise.

• Health practitioners as Key Opinion Leaders Patients as active consumers of healthcare.

This module can contribute to the following programme(s)

LMSLMSC: MSc Skin Lesion Management

LMSIWMSC: MSc Skin Integrity and Wound Management

LMCDMSC: MSc Clinical Dermatology